ALDEVRON
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 08 Feb 2024)
What this means for you
Registered since 05 Sept 2017. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 & §9 renewal is due by 05 Sept 2027, and its filing window is open now).
Record
- Serial number
- 87196801
- Registration number
- 5279694
- Mark type
- Design + words
- Filed
- 07 Oct 2016
- Published for opposition
- 20 Jun 2017
- Registered
- 05 Sept 2017
- Next maintenance filing
- §8 & §9 renewal, due by 05 Sept 2027 (grace period to 05 Mar 2028)
- Attorney of record
- Jessica G. McDonald
Goods and services
- Class 001 — Chemicals: Biochemicals, namely, ribonucleic acids, deoxyribonucleic acids, peptides, proteins, and antibodies for in vitro, in vivo and ex vivo scientific and research use; diagnostic preparations for scientific and research use; diagnostic reagents for scientific and research use; nucleic acids for scientific and research use; proteins in raw material form for scientific and medical research; enzymes for scientific and research use; biochemicals, namely, monoclonal and polyclonal antibodies for in vitro, in vivo, and ex vivo scientific and research use; laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro, in vivo, and ex vivo diagnostic use; biochemicals, namely, ribonucleic acids, deoxyribonucleic acids, peptides, proteins, and antibodies for use in biotechnological product development
- Class 005 — Pharmaceuticals: Biological preparations for use in the treatment of cancer, immune response disorders, genetic conditions, infectious diseases, and vascular diseases; diagnostic preparations for medical and veterinary purposes; diagnostic reagents for medical and veterinary purposes; nucleic acid sequences for medical and veterinary purposes; enzymes for medical and veterinary purposes; protein arrays for medical and veterinary diagnosis purposes; antibodies, namely, monoclonal and polyclonal antibodies for the diagnosis, treatment, and prevention of cancer, immune response disorders, genetic conditions, infectious diseases, and vascular diseases
- Class 040 — Treatment of materials: Manufacturing services for others in the field of biologics for research, clinical and diagnostic applications; technical consultancy services, namely, providing technical advice and information to others related to the manufacture of biologics for research, clinical and diagnostic applications
Owner
- Aldevron, L.L.C., Fargo, ND, US
- Aldevron, L.L.C., Fargo, ND, US
- Aldevron, L.L.C., Fargo, ND, US
Prior registrations
Prosecution history
- 05 Sept 2026 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 05 Sept 2026 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 05 Sept 2026 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 05 Sept 2026 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 22 Oct 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 22 Oct 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 22 Oct 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 22 Oct 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 22 Oct 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 08 Feb 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 08 Feb 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 05 Feb 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 15 Aug 2023 — TEAS SECTION 8 & 15 RECEIVED
- 05 Sept 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 26 Jan 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED